dilithium(1+) ion tetrabromonickeldiuide

• ChemBase编号: 150184
• 分子式: Br4Li2Ni
• 平均质量: 392.1914
• 单一同位素质量: 387.6407
• SMILES: [Li+].[Li+].[Ni-2](Br)(Br)(Br)Br
• Canonical SMILES: Br[Ni-2](Br)(Br)Br.[Li+].[Li+]
• InChI: InChI=1S/4BrH.2Li.Ni/h4*1H;;;/q;;;;2*+1;+2/p-4
• InChIKey: AVJDNPHXGKKFIA-UHFFFAOYSA-J

名称和登记号

名称

• IUPAC标准名: dilithium(1+) ion tetrabromonickeldiuide
• IUPAC传统名: dilithium(1+) ion tetrabromonickelate(2-)
• 别名: 二锂四溴镍酸盐(II); 锂四溴镍酸盐(II) 溶液; 四溴镍酸二锂(II) 溶液; Lithium tetrabromonickelate(II) solution; di-Lithium tetrabromonickelate(II); Dilithium tetrabromonickelate(II) solution

登记号

• CAS号: 13826-95-4
• MDL号: MFCD00192058
• PubChem SID: 162244345; 24866440
• PubChem CID: 11047451

理论计算性质

• 质子受体: 0
• 质子供体: 0
• LogD (pH = 5.5): 3.8964
• LogD (pH = 7.4): 3.8964
• Log P: 3.8964
• 摩尔折射率: 34.9408 cm^3
• 极化性: 17.48607 Å^3
• 极化表面积: 0.0 Å^2
• 可自由旋转的化学键: 0
• 里宾斯基五规则: true

分子性质

理化性质

• 外观: dark blue; liquid
• 沸点: 67 °C
• 闪点: -.4 °F; 0 °F; -18 °C
• 密度: 1.065 g/mL at 25 °C; 1.07 g/mL at 20 °C

安全信息

• 欧盟危险性物质标志: 易燃性(Flammable) (F); 有毒(Toxic) (T)
• 联合国危险货物编号: 1993
• 德国WGK号: 1; 3
• 联合国危险货物等级: 3
• 联合国危险货物包装类别(PG): 2
• 危险公开号: 45-11-19-36/37; 45-11-36/37
• 安全公开号: 53-16-26-33-36/37/39-45; 53-16-26-45
• GHS危险品标识: GHS02; GHS07; GHS08
• GHS警示词: Danger
• GHS危险声明: H225-H319-H335-H350
• GHS警示性声明: P201-P210-P261-P305 + P351 + P338-P308 + P313
• 个人保护装置: Eyeshields, Faceshields, full-face respirator (US), Gloves, multi-purpose combination respirator cartridge (US), type ABEK (EN14387) respirator filter
• RID/ADR: UN 1993 3/PG 2
• 欧盟补充危害声明: May form explosive peroxides.
• 保存温度: 2-8°C

产品相关信息

• 浓度: 0.5 M in THF
• 级别: purum
• 线性分子式: Li2NiBr4

详细说明

Sigma Aldrich - 422592

包装
100, 800 mL in Sure/Seal™
Application
Catalyst for the regioselective preparation of magnetic resonance contrast agents1Reagent for:
• Regioselective synthesis of (-)-gallocatechin2
• Synthesis of ATP mimics3
• Reaction with unsaturated epoxides4

Sigma Aldrich - 62605

Other Notes
用于环氧化物区域选择性和立体选择性开环生成羟基溴化物的试剂5,6,7,8
Application
Catalyst for the regioselective preparation of magnetic resonance contrast agents1Reagent for:
• Regioselective synthesis of (-)-gallocatechin2
• Synthesis of ATP mimics3
• Reaction with unsaturated epoxides4